Intermedia.NET Company Profile

21:06 EST 12th December 2018 | BioPortfolio

Intermedia.NET is the number one US provider of hosted Exchange and Web hosting for small and mid-sized businesses (SMBs). Since 1995, we have given smaller companies the same enterprise-strength IT as large corporations, but delivered as a service over the Internet for a low monthly fee – instead of a large upfront investment.By paying just a few dollars per month for each employee, these smaller companies gain access to the same business email and software that Fortune 500 companies use. And because Intermedia.NET runs these hosted services from our world-class datacenters, which are managed round the clock by a large group of specialist technicians and engineers, they gain Fortune 500-level robustness – quality service with no email downtime. We also provide world-class 24x7 customer support, with extremely knowledgeable staff constantly on hand


156 W 56th Street, suite 1601
New York
New York
United States of America


Phone: 1-212-375-6375
Fax: 1-212-245-1766

News Articles [5 Associated News Articles listed on BioPortfolio]

Intermedia Named Overall Collaboration Winner in CRN's 2018 Annual Report Card

MOUNTAIN VIEW, Calif., Aug. 19, 2018 /PRNewswire/ -- Intermedia, a leading cloud communications and collaboration provider to SMBs and the partners that serve them, announced Read more...

Researchers sequence two selfish genes in the fungus Neurospora intermedia

Selfish genes are genes that are passed on to the next generation but confer no advantage on the individual as a whole, and may sometimes be harmful.

UTA art lecturer wins Puffin Grant

(University of Texas at Arlington) Billi London-Gray, a 2018 graduate of UTA's Master of Fine Arts Intermedia Studio program and a lecturer in the Department of Art and Art History, has won a Puffin F...

Lignocellulose integration to 1G-ethanol process using filamentous fungi: fermentation prospects of edible strain of Neurospora intermedia

Integration of first- and second-generation ethanol processes is one among the alternate approaches that efficiently address the current socio-economic issues of the bioethanol sector. Edible filament...

Unravelling the genetics of fungal fratricide

(Uppsala University) Selfish genes are genes that are passed on to the next generation but confer no advantage on the individual as a whole, and may sometimes be harmful. Researchers at Uppsala Univer...

PubMed Articles [17 Associated PubMed Articles listed on BioPortfolio]

Phenotypic identification of periodontal Prevotella intermedia/nigrescens group isolates validated by MALDI-TOF mass spectrometry.

The accuracy of a phenotypic scheme to recognize periodontal Prevotella intermedia/nigrescens group clinical isolates on primary isolation culture plates was assessed with matrix-assisted laser desorp...

Nutrition of horses with equine pituitary pars intermedia dysfunction ("Cushing's syndrome") treated with pergolid - A field study.

The nutritional status of 36 patients with equine pituitary pars intermedia dysfunction (PPID) under pergolide treatment was investigated.

Morphology, morphogenesis, and phylogeny of an Anteholosticha intermedia (Ciliophora, Urostylida) population from the United States.

A distinct population of Anteholosticha intermedia was isolated from soil in the Great Smoky Mountains of North Carolina, USA, and its morphology, morphogenesis and molecular phylogeny investigated by...

Josamycin suppresses Prevotella intermedia lipopolysaccharide-induced production of nitric oxide and interleukin-1β in murine macrophages.

Josamycin has immunomodulatory properties independent of its antibacterial actions. This study was designed to explore the influences and associated mechanisms of josamycin upon the generation of proi...

Quorum sensing molecules regulate epithelial cytokine response and biofilm-related virulence of three Prevotella species.

Quorum sensing (QS) signaling regulates the motility, adhesion, and biofilm formation of bacteria, and at the same time activates immune response in eukaryotic organisms. We recently demonstrated that...

Clinical Trials [15 Associated Clinical Trials listed on BioPortfolio]

Combination Therapy of Hydroxyurea With L-Carnitine and Magnesium Chloride in Thalassemia Intermedia

The purpose of this study is determination of the efficacy of combination of hydroxyurea with L-carnitine or magnesium in improving hematologic parameters and cardiac status in patients w...

Efficacy and Safety of Low Dose Thalidomide in Thalassemia Intermedia

Thalidomide is known to have hypnosedative, immuno-modulatory and anti-angiogenic effects. The drug is widely used in several neoplastic disorders (e.g. multiple myeloma and malignant mela...

Evaluating the Safety and Effectiveness of Decitabine in People With Thalassemia Intermedia

Thalassemia intermedia (TI) is an inherited blood disorder that can cause anemia due to low levels of hemoglobin. Decitabine is a medication that may be effective at increasing hemoglobin ...

The Effect of Different Dental Implant Surface Characteristics on Immunological and Microbiological Parameters

Objectives: To assess the levels of TNF-α, PGE2, RANKL, RANK, OPG, which are immunological markers of peri-implant disease and F. nucleatum, P. gingivalis, T. denticola, T. forsythia, P. ...

Phase II Study of Arginine Butyrate With or Without Epoetin Alfa in Patients With Thalassemia Intermedia

OBJECTIVES: I. Determine whether arginine butyrate with or without epoetin alfa can stimulate gamma-globin chain production to a degree that decreases anemia and results in hematologic im...

Companies [2 Associated Companies listed on BioPortfolio]


Intermedia.NET is the number one US provider of hosted Exchange and Web hosting for small and mid-sized businesses (SMBs). Since 1995, we have given smaller companies the same enterprise-strength IT a...

Inter/Media Advertising

Inter/Media Advertising is a fully integrated $450-million advertising agency and media organization that uniquely blends direct response advertising with general market techniques. Founded in 1974 a...

More Information about "Intermedia.NET" on BioPortfolio

We have published hundreds of Intermedia.NET news stories on BioPortfolio along with dozens of Intermedia.NET Clinical Trials and PubMed Articles about Intermedia.NET for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Intermedia.NET Companies in our database. You can also find out about relevant Intermedia.NET Drugs and Medications on this site too.

Quick Search


Corporate Database Quicklinks

Searches Linking to this Company Record